FindMyRecallSubscribe
Class I: serious health riskTerminated

Fresenius Kabi Magnesium Sulfate Injection Recall

Magnesium Sulfate Injection, USP, 50% (25 grams/50 mL), For IM or IV Use, 50 mL, Single…

Fresenius Kabi USA, LLC · Lake Zurich, IL

Risk level
Class I
Reported by FDA
Sep 4, 2013
Recall ID
D-920-2013
Check your lot numberHow we source this data

Summary

Fresenius Kabi recalled Magnesium Sulfate Injection starting May 25, 2013. The FDA classified it as Class I (serious health risk) and published enforcement report D-920-2013 on Sep 4, 2013. Reason: Presence of Particulate Matter: Glass particulate matter was observed in a retention sample during an annual review. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: Glass particulate matter was observed in a retention sample during an annual review.

Product description

Magnesium Sulfate Injection, USP, 50% (25 grams/50 mL), For IM or IV Use, 50 mL, Single Dose Vial, Rx only, Preservative Free, APP Pharmaceuticals, LLC, Schaumburg, IL, 60173, NDC 63323-064-50

Lot numbers, UPCs & expiration codes

Lot #: 6103882, Exp 10/14

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-920-2013
Classification
Class I
Status
Terminated
Recall initiated
May 25, 2013
FDA report date
Sep 4, 2013
Quantity
15,625 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Fresenius Kabi USA, LLC

Original FDA data

Every field from FDA enforcement report D-920-2013, exactly as published.

Show all FDA fields
City
Lake Zurich
State
IL
Status
Terminated
Country
United States
Event ID
65218
Address
3 Corporate Dr
Code information
Lot #: 6103882, Exp 10/14
Postal code
60047-8930
Report date
Sep 4, 2013
Product type
Drugs
Recall number
D-920-2013
Classification
Class I
Recalling firm
Fresenius Kabi USA, LLC
Product quantity
15,625 vials
Termination date
Mar 10, 2016
Reason for recall
Presence of Particulate Matter: Glass particulate matter was observed in a retention sample during an annual review.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Magnesium Sulfate Injection, USP, 50% (25 grams/50 mL), For IM or IV Use, 50 mL, Single Dose Vial, Rx only, Preservative Free, APP Pharmaceuticals, LLC, Schaumburg, IL, 60173, NDC 63323-064-50
Distribution pattern
Nationwide
Recall initiation date
May 25, 2013
Initial firm notification
Letter
Center classification date
Aug 23, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-920-2013, published Sep 4, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls